Literature DB >> 24560109

Hilar cholangiocarcinoma.

Victor M Zaydfudim1, Charles B Rosen2, David M Nagorney3.   

Abstract

Optimal treatment of hilar cholangiocarcinoma depends on location of the cancer and extent of biliary and vascular involvement. Candidates for resection or transplantation must be evaluated and managed by a multidisciplinary team at a high-volume hepatobiliary center. Success requires absence of distant nodal or extrahepatic metastases and an adequate functional liver remnant with a negative ductal margin. Ipsilateral portal vein resection and reconstruction should be performed in patients with venous involvement. Neoadjuvant chemoradiation and liver transplantation is the best treatment option for patients with unresectable hilar cholangiocarcinoma without nodal or distant metastases and for patients with underlying chronic liver disease.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hepatic resection; Hilar cholangiocarcinoma; Liver transplantation; Vascular resection

Mesh:

Year:  2014        PMID: 24560109     DOI: 10.1016/j.soc.2013.10.005

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN: 1055-3207            Impact factor:   3.495


  14 in total

1.  Regional thermochemotherapy versus hepatic arterial infusion chemotherapy for palliative treatment of advanced hilar cholangiocarcinoma: a retrospective controlled study.

Authors:  Yaoting Chen; Huiqing Li; Xiongying Jiang; Dong Chen; Jiayan Ni; Hongliang Sun; Jianghong Luo; Herui Yao; Linfeng Xu
Journal:  Eur Radiol       Date:  2016-01-28       Impact factor: 5.315

Review 2.  The role of interventional radiology in the treatment of intrahepatic cholangiocarcinoma.

Authors:  Anna Maria Ierardi; Salvatore Alessio Angileri; Francesca Patella; Silvia Panella; Natalie Lucchina; Elena N Petre; Antonio Pinto; Giuseppe Franceschelli; Gianpaolo Carrafiello; Gianpaolo Cornalba; Constantinos T Sofocleous
Journal:  Med Oncol       Date:  2016-12-22       Impact factor: 3.064

3.  Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).

Authors:  Jesus M Banales; Vincenzo Cardinale; Guido Carpino; Marco Marzioni; Jesper B Andersen; Pietro Invernizzi; Guro E Lind; Trine Folseraas; Stuart J Forbes; Laura Fouassier; Andreas Geier; Diego F Calvisi; Joachim C Mertens; Michael Trauner; Antonio Benedetti; Luca Maroni; Javier Vaquero; Rocio I R Macias; Chiara Raggi; Maria J Perugorria; Eugenio Gaudio; Kirsten M Boberg; Jose J G Marin; Domenico Alvaro
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-04-20       Impact factor: 46.802

4.  Aspirin use and the risk of cholangiocarcinoma.

Authors:  Jonggi Choi; Hassan M Ghoz; Thoetchai Peeraphatdit; Esha Baichoo; Benyam D Addissie; William S Harmsen; Terry M Therneau; Janet E Olson; Roongruedee Chaiteerakij; Lewis R Roberts
Journal:  Hepatology       Date:  2016-04-26       Impact factor: 17.425

5.  Clinical Factors and Postoperative Impact of Bile Leak After Liver Resection.

Authors:  Allison N Martin; Sowmya Narayanan; Florence E Turrentine; Todd W Bauer; Reid B Adams; George J Stukenborg; Victor M Zaydfudim
Journal:  J Gastrointest Surg       Date:  2017-12-15       Impact factor: 3.452

6.  IgG4-Associated Cholangitis Can Mimic Hilar Cholangiocarcinoma.

Authors:  Victor M Zaydfudim; Andrew Y Wang; Eduard E de Lange; Zimin Zhao; Christopher A Moskaluk; Todd W Bauer; Reid B Adams
Journal:  Gut Liver       Date:  2015-07       Impact factor: 4.519

7.  Systemic inflammation score predicts survival in patients with intrahepatic cholangiocarcinoma undergoing curative resection.

Authors:  Yong Zhang; Shi-Ming Shi; Hua Yang; Liu-Xiao Yang; Zheng Wang; Xue-Dong Li; Dan Yin; Ying-Hong Shi; Ya Cao; Zhi Dai; Jian Zhou; Qing Chen
Journal:  J Cancer       Date:  2019-01-01       Impact factor: 4.207

Review 8.  Radiological Imaging for Assessing the Respectability of Hilar Cholangiocarcinoma: A Systematic Review and Meta-Analysis.

Authors:  Hongchen Zhang; Jian Zhu; Fayong Ke; Mingzhe Weng; Xiangsong Wu; Maolan Li; Zhiwei Quan; Yingbin Liu; Yong Zhang; Wei Gong
Journal:  Biomed Res Int       Date:  2015-09-01       Impact factor: 3.411

9.  Characterizing the activation of the Wnt signaling pathway in hilar cholangiocarcinoma using a tissue microarray approach.

Authors:  W Chen; J Liang; L Huang; J Cai; Y Lei; J Lai; L Liang; K Zhang
Journal:  Eur J Histochem       Date:  2016-02-09       Impact factor: 3.188

10.  Impact of Preoperative Three-Dimensional Computed Tomography Cholangiography on Postoperative Resection Margin Status in Patients Operated due to Hilar Cholangiocarcinoma.

Authors:  A Andert; P Bruners; C Heidenhain; F Ulmer; C D Klink; P H Alizai; C Kuhl; U P Neumann; M Binnebösel
Journal:  Gastroenterol Res Pract       Date:  2017-08-16       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.